On Jun. 17-20, 2018, the Complex Cardiovascular Catheter Therapeutics conference was held in Orlando, US.
The SJVF 2018 was held from June 1 to 3, 2018. Lifetech was invited to the conference and held a session.
From May 31 to June 3, 2018, the OCC 2018 was held in Shanghai. Lifetech was invited to the conference, and demonstrated the LAmbre™ through the live demonstration of a procedure.
On May 22-25, 2018, the EuroPCR 2018 was held in Paris, France. Lifetech attended the event, and demonstrated its innovation strength in the field of interventional cardiology.
On May 25-27, 2018, China Youth Electrophysiology -Pacing Symposium (CYES) was successfully held at the Wuhan East Lake International Convention Center.
Lifetech announced that Ally-Bridge-Lifetech, a joint venture set up by it in partnership with Ally Bridge Group
On May 12, 2018, the 2018 NCCD Structural Heart Disease Forum was held at the Fuwai Cardiovascular Hospital of Yunnan Province.
On May 13-15, 2018, Lifetech joined hands with the Fuwai Hospital Affiliated to the Chinese Academy of Medical Sciences to completed the world's first human implantation of the aortic stent graft system.
On May 15, 2018, Shanghai Tenth People's Hospital became the first center in China to complete 100 implantations of LAmbre™ left atrial appendage (LAA) occluder.
On May 6, 2018, Lifetech joined hands with the Shanghai Chest Hospital to held a Seminar on LAA Closure.